TY  - GEN
AU  - Moreau,Philippe
AU  - Pylypenko,Halyna
AU  - Grosicki,Sebastian
AU  - Karamanesht,Ievgenii
AU  - Leleu,Xavier
AU  - Rekhtman,Grigoriy
AU  - Masliak,Zvenyslava
AU  - Robak,Pawel
AU  - Esseltine,Dixie-Lee
AU  - Feng,Huaibao
AU  - Deraedt,William
AU  - van de Velde,Helgi
AU  - Arnulf,Bertrand
TI  - Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study
SN  - 1592-8721
PY  - 2015///1022
KW  - Administration, Cutaneous
KW  - Administration, Intravenous
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Boronic Acids
KW  - Bortezomib
KW  - Humans
KW  - Multiple Myeloma
KW  - complications
KW  - Neoplasm Recurrence, Local
KW  - Pyrazines
KW  - Renal Insufficiency
KW  - etiology
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Letter; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3324/haematol.2014.118182
ER  -